AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Akglim-M 1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Akned Healthcare Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Akglim-M 1 Tablet PR

DiaBetaDuo, a single-dose tablet, is an antidiabetic medication combining two active ingredients for adult type 2 diabetes management. It effectively regulates blood glucose. Administer DiaBetaDuo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. DiaBetaDuo is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should consult their physician before starting DiaBetaDuo. Pregnant or breastfeeding individuals require medical advice before use. Regular blood glucose monitoring, along with potential blood tests for blood cell counts and liver function, are recommended by your doctor.

Primary Ingredients of Akglim-M 1 Tablet PR

No text provided to rephrase.

Uses of Akglim-M 1 Tablet PR

Managing Type 2 diabetes

Major Benefits of Akglim-M 1 Tablet PR:

Follow your doctor's instructions or consult the product label for proper administration. Take one Akglim-M tablet (PR) with meals.

Common Side effects of Akglim-M 1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Akglim-M 1 Tablet PR:

Follow your physician's instructions or refer to the product label for usage guidelines. Administer one Akglim-M PR tablet with a meal.

How Akglim-M 1 Tablet PR works:

Akglim-M 1 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Akglim-M 1 Tablet PR with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Akglim-M 1 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Medical advice is recommended.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should not take Akglim-M 1 Tablet PR. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Akglim-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Akglim-M 1 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Akglim-M 1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose of Akglim-M 1 Tablet PR is typically prescribed for individuals with mild to moderate liver disease; its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Akglim-M 1 Tablet PR :

Should you forget to take a single Akglim-M tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Akglim-M 1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Akglim-M 1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Akglim-M 1 Tablet PR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Akglim-M 1 Tablet PR and seek immediate medical attention.
Akglim-M 1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for treating type 1 DM.
Akglim-M 1 Tablet PR may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Akglim-M 1 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Akglim-M 1 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Akglim-M 1 Tablet PR with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Akglim-M 1 Tablet PR
104
MRP 120
13% off